IGF::OT::IGF SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
$132,775N02FY2015CANIH
Investigators
Abstract
Indenos for Injection Clinical Lot. This agent is being developed in support of ongoing Phase I/2 clinical trials at several institutions. These supplies are needed to support these human clinical trials.
View original record on NIH RePORTER →